Predictors of chronic idiopathic thrombocytopenic purpura
- PMID: 20405514
- DOI: 10.1002/pbc.22481
Predictors of chronic idiopathic thrombocytopenic purpura
Abstract
Background: Idiopathic thrombocytopenic purpura is a hematological disorder with heterogeneous manifestation and unpredictable outcome. This study reviewed the pattern of presentation and response to therapy in patients with ITP, in order to identify risk factors for chronic disease.
Procedure: The study included all patients diagnosed as ITP between January 1998 and December 2007.
Results: Sixty-five percent of the patients had acute and 34.9% had chronic ITP. Patients with chronic ITP had a higher mean age at diagnosis (P = 0.0000003). Females more than 10 years of age were more susceptible than males to follow a chronic course (P = 0.031). Febrile illness preceded the onset of ITP in 167 patients, 76.0% of them had an acute course (P = 0.000037). Moderate and severe bleeding occurred in 11.34% and 7.27% of the patients, respectively. Fifty-four patients (15.7%) improved without any specific treatment. Corticosteroids were used as a first-line treatment in 209 patients and showed a total response of 76.6% compared to 85.7% and 84% for IVIG and anti-D immunoglobulin treated patients, respectively.
Conclusion: The most relevant risk factors for the development of chronic ITP included a gradual mode of onset of symptoms over more than 2 weeks period, initial platelet count >20 x 10(9)/L, and age more than 10 years at presentation.
Copyright 2010 Wiley-Liss, Inc.
Similar articles
-
Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity?Arch Dis Child. 2007 Aug;92(8):704-7. doi: 10.1136/adc.2006.098442. Epub 2007 Apr 25. Arch Dis Child. 2007. PMID: 17460024 Free PMC article.
-
[Childhood idiopathic thrombocytopenic purpura (the results of 20-year experience)].Georgian Med News. 2009 Sep;(174):50-5. Georgian Med News. 2009. PMID: 19801732 Russian.
-
Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.Acta Haematol. 2006;115(1-2):46-52. doi: 10.1159/000089465. Acta Haematol. 2006. PMID: 16424649 Clinical Trial.
-
Acute immune (idiopathic) thrombocytopenic purpura in childhood.Blood Rev. 2002 Mar;16(1):19-21. doi: 10.1054/blre.2001.0175. Blood Rev. 2002. PMID: 11913988 Review.
-
Childhood acute immune thrombocytopenic purpura: 20 years later.Semin Thromb Hemost. 2003 Dec;29(6):605-17. doi: 10.1055/s-2004-815628. Semin Thromb Hemost. 2003. PMID: 14719177 Review.
Cited by
-
Spontaneous improvement of chronic immune thrombocytopenia in children: experience of 56 patients at a single institute.Int J Hematol. 2012 Dec;96(6):729-32. doi: 10.1007/s12185-012-1211-x. Epub 2012 Oct 27. Int J Hematol. 2012. PMID: 23104260
-
Guidelines on the diagnosis of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2012.Rev Bras Hematol Hemoter. 2013;35(5):358-65. doi: 10.5581/1516-8484.20130105. Rev Bras Hematol Hemoter. 2013. PMID: 24255621 Free PMC article. No abstract available.
-
Identification of predictive factors for response to intravenous immunoglobulin treatment in children with immune thrombocytopenia.Int J Hematol. 2014;99(5):597-602. doi: 10.1007/s12185-014-1551-9. Epub 2014 Feb 27. Int J Hematol. 2014. PMID: 24573984
-
Chronic Pediatric Immune Thrombocytopenia Is Not Associated With Herpes Virus Infection Status.Front Pediatr. 2021 Dec 2;9:641535. doi: 10.3389/fped.2021.641535. eCollection 2021. Front Pediatr. 2021. PMID: 34926334 Free PMC article.
-
Clinical course and prognostic factors of childhood immune thrombocytopenia: single center experience of 10 years.Korean J Pediatr. 2016 Aug;59(8):335-40. doi: 10.3345/kjp.2016.59.8.335. Epub 2016 Aug 24. Korean J Pediatr. 2016. PMID: 27610182 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources